课题基金 / 基金详情

The development of radiolabelled ghrelin analogues for the molecular imaging of prostate cancer through targeting the growth hormone secretagogue receptor.

The development of radiolabelled ghrelin analogues for the molecular imaging of prostate cancer through targeting the growth hormone secretagogue receptor.
通过靶向生长激素促分泌受体,开发放射性标记的生长素释放肽类似物,用于前列腺癌的分子成像。
批准号:
253852
负责人:
Luyt Leonard G
金额:
$28.61万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-03-01 至 2015-03-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer is the most commonly diagnosed cancer in Canadian men with over 20,000 cases expected in 2010. Early and accurate diagnosis of the disease is critical for effective treatment planning and especially important is the ability to correctly id
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金